Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
Advertisement
The Scientist
Most Recent
How plants pass defenses to offspring through a complex molecular network
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
The diversity of microbes in the great outdoors may protect against inflammatory disorders.
The FDA and NIH dispute reports that clinical trial data is being under-reported.
More collaborators and more data are the key ingredients.
Techniques for simpler, cheaper, and better antibody purification
A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.
What lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review.
A combination of antibiotics and the body’s own defensive metabolites clears bacterial infections faster than antibiotics alone.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
